The global sales of medical specialty bag are estimated to be worth USD 9,606.1 million in 2025 and anticipated to reach a value of USD 15,351.8 million by 2035. Sales are projected to rise at a CAGR of 4.8% over the forecast period between 2025 and 2035. The revenue generated by medical specialty bag in 2024 was USD 9,178.6 million. The industry is anticipated to exhibit a Y-o-Y growth of 4.6% in 2025.
The growing need for medicine bags in the medical specialty bag market, projected to reach USD 4,351.6 million by 2025 with a market share of over 45%, is necessitated by the growing incidence of chronic diseases, hospitalization, and requirement for safe and contamination-free handling and transport of medicines.
Growing home healthcare services, fueled by the aging population and remote patient monitoring technologies, have also fueled the demand for unit-dose packages and tamper-evident medicine bags. Besides, stringent regulatory needs for drug safety, sterility, and FDA and EU compliance are compelling pharmaceutical companies and healthcare centers to use high-barrier, antimicrobial, and eco-friendly materials, further propelling the growth of the market.
Global Medical Specialty Bag Industry Assessment
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 9,606.1 million |
| Industry Value (2035F) | USD 15,351.8 million |
| CAGR (2025 to 2035) | 4.8% |
IV bags are the most commonly used, and the market is expected to reach USD 3,342.9 million by 2025. They are widely used in hospitals, clinics, and home healthcare for fluid management, drug delivery, and parenteral nutrition. The bags are indispensable for the administration of saline solutions, dextrose, Ringer's lactate, antibiotics, chemotherapy agents, and total parenteral nutrition (TPN) in intravenous treatment patients.
The demand increases with the raising incidence of chronic diseases like cancers, diabetes mellitus, gastrointestinal diseases, surging number of surgeries, accident cases, and ICU admissions. The trend also towards PVC-free, DEHP-free, multi-chambered IV bags offering better stability, reduced risk of contamination, increased patient safety for which the overall market growth in the IV equipment is accelerating in the market.
The below table presents the expected CAGR for the global medical specialty bag market over several semi-annual periods spanning from 2025 to 2035. In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 5.3%, followed by a low growth rate of 4.3% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 5.3% (2024 to 2034) |
| H2 | 4.3% (2024 to 2034) |
| H1 | 5.5% (2025 to 2035) |
| H2 | 4.1% (2025 to 2035) |
Moving into the subsequent period, from H1 2024 to H2 2035, the CAGR is projected to increase to 5.5% in the first half and decrease to 4.1% in the second half. In the first half (H1) the market witnessed an increase of 20 BPS while in the second half (H2), the market witnessed a decrease of 20 BPS.
Chronic Diseases and Aging Population Boost Demand for Specialty Bags
Increasing conditions of chronic disorders, such as diabetes, renal disorders, diseases of the stomach and intestines, and oncological diseases drive the demand of medical specialty bags, including iv bags, CAPD bags and enteral nutritional bags. Specialty bags ensure both safe and adequate drug and liquid administration for constant medication, dialysis, or enteral nutritional needs.
The elderly population is increasingly getting old in most parts of the world. It has higher incidents of age-related diseases requiring prolonged hospital stays, home health care products, and palliative care. The aged population is also more susceptible to dehydration, malnutrition, and chronic diseases that necessitate an increase in urinary collection bags, bile collection bags, and medical waste bags.
Additionally, developments of home-based medical care and ambulatory surgical centers have further created demand for handy, sterile, and disposable medical bags, in which patients feel safe, the risk of infections is reduced, and healthy conditions are ensured.
Rising Surgeries and Home Care Drive Demand for Critical Care Bags
Surgeons, emergency admissions, and admission to ICU increase. Therefore, the medical specialty bags required by the medical world will include more anesthesia breathing bags, blood bags, resuscitation bags, and urinary collection bags.
Apart from trauma, cardiovascular diseases, and organ transplants, demand has also improved for post-operative fluid management and respiratory support, and therefore, critical care bags have gone up in demand. Growth in the number of ASCs and same-day surgical procedures with short hospital stays also helped raise use of single use, sterile bags to prevent infections in those locations.
The trend is home-based treatments and post-operations, generally driven by issues of cost-efficiency and for the convenience of patients, creating further demand in disposable urine drainage bags, wound drainage bags and enteral feeding bags. The technological advancements in the infection control and biocompatible materials also strengthen the market growth.
Regulatory Pressure and Infrastructure Gaps Worsen Medical Bag Waste Crisis
The disposal of PVC-based, single-use, and non-biodegradable medical bags poses a challenge because of the stringent regulations in waste management that intend to minimize environmental and health hazards. Most of the IV bags, blood bags, urinary collection bags, and biomedical waste bags are composed of PVC and other non-recyclable plastics, therefore producing huge amounts of medical waste that require specific incineration or disposal.
The EPA, WHO, and EU MDR have made strenuous regulations surrounding the segregation, handling, and disposal of medical waste, driving up the operation costs of the hospitals, clinics, and manufacturing firms.
However, the issue is worse on developing economies lacking the proper structures of recycling plants, waste management facilities, as well as dumping systems, contributing to illegal dumping, environmental poisoning, and dangers to health. Although the market is slowly shifting towards more biodegradable, DEHP-free, and latex-free materials, still the exorbitant and scarce availability of an eco-friendly material is hampering its universal acceptance.
The global medical specialty bag industry recorded a CAGR of 4.1% during the historical period between 2020 and 2024. The growth of the medical specialty bag industry was positive as it reached a value of USD 9,178.6 million in 2024 from USD 7,794.1 million in 2020.
The market of medical specialty bags has been continuously growing over the last few years primarily due to the continuously increasing incidence of chronic diseases, rising surgical procedures, and an increase in adoption of home healthcare. Exponential growth in IV bags, CAPD bags, and enteral feeding bags can be attributed to an exploding population with increasing long-term care requirements related to kidney failure and gastrointestinal disorders, and also cancer conditions.
The intensified infection control mainly within the hospital and outpatient surgical facility demands mostly single-use sterile medical sacks. In addition, regulatory guidance in the directives of DEHP-free and PVC-free materials played a great role in introducing new products since manufacturers looked for biocompatibility and recyclable alternative materials as healthcare facilities become more open to changing times.
This tension in the supply chain and lack of raw materials has also triggered a big impact with regard to market fluctuation along with strategic stockpiling through health facilities in their bid to mitigate the interruption in the critical supply of medical bags.
Demand for medical specialty bags is likely to go up with the increasing innovation in bio-based polymers, advanced barrier properties, and deployment of smart packaging technologies. However, the maximum acceleration of CAPD bags, ostomy bags, and urinary collection bags is going to be realized with the rise of personalized medicine and at-home care solutions for an expanded customer base mainly from the older demographics and post-surgical patients.
The other area would be sustainability issues through which the manufacturers would focus on biodegradable and recyclable medical bags as a response to the very strict norms brought into place within the area of waste management.
This would lead to a larger percentage of cost-effective, multi-layered medical bags too, since developing economies raise health infrastructure as well as increase insurance coverage for diversified treatment applications. Smart infusion bags will also carry infusion of RFID tracking and antimicrobial coatings, ensuring greater safety, traceability, and a longer shelf life for critical medical fluids.
Tier 1 company leaders are characterized by high production technology and a wide product portfolio. These market leaders are distinguished by their extensive expertise in manufacturing and reconditioning across multiple packaging formats and a broad geographical reach, underpinned by a robust consumer base.
They provide a wide range of series including reconditioning, recycling, and manufacturing utilizing the latest technology and meeting the regulatory standards providing the highest quality. Prominent companies within Tier 1 include Baxter International Inc., B. Braun SE, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Cardinal Health, 3M.
Tier 2 companies are characterized by a strong presence overseas and strong market knowledge. These market players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in Tier 2 include Coloplast A/S, Convatec Group PLC, Hollister Incorporated, Terumo Corporation, Teleflex Incorporated.
Tier 3 includes the majority of small-scale companies operating at the local presence and serving niche markets. These companies are notably oriented towards fulfilling local market demands and are consequently classified within the tier 3 share segment.
They are small-scale players and have limited geographical reach. Tier 3, within this context, is recognized as an unorganized market, denoting a sector characterized by a lack of extensive structure and formalization when compared to organized competitors.
The section below covers the industry analysis for the medical specialty bag market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided. USA is anticipated to remain at the forefront in North America, with a CAGR of 3.1% through 2035. In South Asia & Pacific, India is projected to witness a CAGR of 6.7% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| USA | 3.1% |
| Canada | 2.4% |
| Brazil | 4.7% |
| Argentina | 5.3% |
| Germany | 1.9% |
| China | 5.8% |
| India | 6.7% |
The increasing adoption of home-based dialysis treatment has fueled demand for CAPD bags in the USA medical specialty bags market. It is because PD is increasingly getting preference over hemodialysis on account of increased convenience, decreased hospital visits, and lower rates of infection, thus leading towards patient-centric as well as cost-effective treatment avenues.
Leading healthcare providers and dialysis centers are promoting CAPD more than conventional in-center dialysis, because it enables the patient with CKD to be maintained in the comfort of their home with minimal assistance. The scarcity of nephrologists and presence of fewer dialysis centers in rural areas is another reason that is propelling the use of CAPD.
Regulatory support in the form of Medicare coverage under the ESRD Treatment Choices (ETC) Model is driving home-based dialysis; therefore, the requirement for high-quality, sterile CAPD bags exists in the USA medical specialty bags market.
The increasing demand for biodegradable biomedical waste bags is among the key drivers in the German medical specialty bags market, largely due to stringent medical waste disposal regulations under Germany's KrWG (Circular Economy Act) and the Ordinance on the Management of Healthcare Waste.
Hospitals, clinics, and diagnostic centers need to follow strictly the segregation of waste, followed by sterilization and eco-friendly disposal, so there is immense pressure on hospitals to adopt the use of PVC-free, latex-free, and biodegradable waste bags.
In addition, the DSD of Germany requires strict recycling rules, which makes healthcare facilities adopt compostable and incineration-friendly materials for collecting medical waste. The increasing infection control measures after COVID-19 have further increased the demand for sterile, leak-proof, and high-barrier biomedical bags, especially in hospitals with advanced waste autoclaving systems. Major companies in Germany are investing in bio-based polymer medical bags as part of the country's goal of achieving net-zero medical waste emissions by 2045.
The section contains information about the leading segments in the industry. By bag type, IV bags are projected to grow at a CAGR of 4.8% through 2025 to 2035. Additionally, medicine bags applications are predicted to grow at a CAGR of 4.6%.
| Material Type | Value Share (2025) |
|---|---|
| Polypropylene (PP) | 35.1% |
Polypropylene (PP) is expected to lead the market in terms of value, driven by its high chemical resistance, low leachability, and superior sterilization compatibility, which makes it the preferred material for IV bags, CAPD bags, and enteral feeding bags. In contrast to PVC, which needs plasticizers such as DEHP, PP-based bags are non-toxic and DEHP-free, thus reducing the risks of contaminant migration in parenteral nutrition and dialysis solutions.
The major healthcare providers are now adopting the multi-layered PP bags for total parenteral nutrition and chemotherapy drugs to ensure extended shelf life and minimal interaction of drugs. The PP bags are autoclavable, lightweight, and recyclable, targeting the growing needs of green medical packaging solutions aligned with the strict regulations from USA FDA and EU MDR.
Major medical bag manufacturers are investing significantly in PP-based multilayer films, thereby improving durability and barrier properties against oxygen and moisture, further enhancing its market supremacy.
| Capacity | Value Share (2025) |
|---|---|
| 501-1000 ml | 42.7% |
The most favored capacity segment of the medical specialty bag market is 501-1000 ml, mainly due to its optimum volume for critical applications such as intravenous (IV) therapy, total parenteral nutrition (TPN), and peritoneal dialysis. This range is commonly applied in hospitals, ambulatory surgical centers (ASCs), and home healthcare environments, which ensure fluid administration efficiency and patient convenience.
For CAPD and enteral nutrition, 500-1000 ml bags are used to achieve a suitable volume for single-use sessions, minimizing the number of bag changes while maintaining sterility. In post-operative care and ICUs, this capacity is ideal for fluid resuscitation, electrolyte balancing, and controlled drug infusion.
Manufacturers are nowadays focusing on multi-chamber designs in the range of 500-1000 ml for TPN and chemotherapy applications, such as precise dosing and extended stability of sensitive formulations. This capacity is also seeing the trend of PVC-free, DEHP-free bags, which are in line with global regulatory trends.
Key players operating in the medical specialty bag market are investing in the development of innovative sustainable solutions and also entering into partnerships. Key medical specialty bag providers have also been acquiring smaller players to grow their presence to further penetrate the medical specialty bag market across multiple regions.
Recent Industry Developments in the Medical Specialty Bag Market
In terms of material type, the industry is divided into polypropylene (PP), polyethylene (PE), polyvinyl chloride (PVC), ethylene-vinyl acetate (EVA), and others (Aluminum, Latex Free etc.).
In terms of capacity, the industry is segregated into up to 250 ml, 251 - 500 ml, 501 - 1000 ml, and above 1000 ml.
By bag type, the market is divided into anesthesia breathing bags, bile collection bags, ostomy bags, resuscitation bags, blood bags, CAPD bags, enema bags, enteral feeding bags, IV bags, urinary collection bags, others (specimen bags, pressure infuser bags, etc.).
The market is classified by applications such as medicine bags, surgical bags, medical supply bags, medical waste bags, biomedical bags.
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, and the Middle East & Africa have been covered in the report
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 4: Global Market Volume (Units) Forecast by Product, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 6: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 8: North America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 10: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 11: Latin America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 12: Latin America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 15: Western Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 16: Western Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 18: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 19: Eastern Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 20: Eastern Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 22: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 24: South Asia and Pacific Market Volume (Units) Forecast by Product, 2019 to 2034
Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 27: East Asia Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 28: East Asia Market Volume (Units) Forecast by Product, 2019 to 2034
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 30: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 32: Middle East and Africa Market Volume (Units) Forecast by Product, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Product, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 3: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 4: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 7: Global Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 8: Global Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 9: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 11: Global Market Attractiveness by Product, 2024 to 2034
Figure 12: Global Market Attractiveness by Region, 2024 to 2034
Figure 13: North America Market Value (US$ Million) by Product, 2024 to 2034
Figure 14: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 15: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 16: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 17: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 18: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 19: North America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 20: North America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 21: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 22: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 23: North America Market Attractiveness by Product, 2024 to 2034
Figure 24: North America Market Attractiveness by Country, 2024 to 2034
Figure 25: Latin America Market Value (US$ Million) by Product, 2024 to 2034
Figure 26: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 27: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 28: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 29: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 30: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 31: Latin America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 32: Latin America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 33: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 34: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 35: Latin America Market Attractiveness by Product, 2024 to 2034
Figure 36: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 37: Western Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 38: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 39: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 40: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 41: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 42: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 43: Western Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 44: Western Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 45: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 46: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 47: Western Europe Market Attractiveness by Product, 2024 to 2034
Figure 48: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 49: Eastern Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 50: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 51: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 52: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 53: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 54: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 55: Eastern Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 56: Eastern Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 57: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 58: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 59: Eastern Europe Market Attractiveness by Product, 2024 to 2034
Figure 60: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 61: South Asia and Pacific Market Value (US$ Million) by Product, 2024 to 2034
Figure 62: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 63: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 64: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 65: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 66: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 67: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 68: South Asia and Pacific Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 69: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 70: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 71: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034
Figure 72: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 73: East Asia Market Value (US$ Million) by Product, 2024 to 2034
Figure 74: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 75: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 76: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 77: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 78: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 79: East Asia Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 80: East Asia Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 81: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 82: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 83: East Asia Market Attractiveness by Product, 2024 to 2034
Figure 84: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 85: Middle East and Africa Market Value (US$ Million) by Product, 2024 to 2034
Figure 86: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 87: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 88: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 89: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 90: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 91: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 92: Middle East and Africa Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 93: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 94: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 95: Middle East and Africa Market Attractiveness by Product, 2024 to 2034
Figure 96: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
The global medical specialty bag industry is projected to witness CAGR of 4.8% between 2025 and 2035.
The global medical specialty bag industry stood at USD 9,178.6 million in 2024.
The global medical specialty bag industry is anticipated to reach USD 15,351.8 million by 2035 end.
South Asia & Pacific region is set to record the highest CAGR of 5.9% in the assessment period.
The key players operating in the global medical specialty bag industry include Baxter International Inc., B. Braun SE, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Cardinal Health, 3M.
Explore Similar Insights
Medical Specialty Bag Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
